Related Experiment Video
Updated: May 17, 2025

Urinary Bladder Distention Evoked Visceromotor Responses as a Model for Bladder Pain in Mice
Published on: April 27, 2014
Pathophysiology and potential multimodal therapeutic strategies for IC/BPS
Jia-Fong Jhang1, Wan-Ru Yu1, Yuan-Hong Jiang1
1Department of Urology, Hualien Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, and Tzu Chi University, Hualien, Taiwan.
Interstitial cystitis/bladder pain syndrome (IC/BPS) is a complex bladder condition with varied symptoms and causes. A proposed algorithm for multimodal therapy aims to address its multifaceted nature, offering a structured approach to treatment.
Area of Science:
- Urology
- Pain Medicine
- Immunology
Background:
- Interstitial cystitis/bladder pain syndrome (IC/BPS) presents with diverse clinical symptoms and presentations.
- The etiology of IC/BPS is not well-defined, contributing to a lack of effective treatments.
- Multiple factors, including urothelial dysfunction, mast cell activation, and neurogenic inflammation, are implicated in IC/BPS.
Purpose of the Study:
- To propose a rational algorithm for concomitant multimodal therapy in IC/BPS.
- To address the need for a defined therapeutic strategy for this complex bladder disorder.
- To guide clinicians in managing the varied pathological mechanisms of IC/BPS.
Main Methods:
- Review of current understanding of IC/BPS pathophysiology.
- Analysis of existing non-pharmacological, medical, and intravesical therapies.
- Development of a structured algorithm for multimodal treatment approaches.
Main Results:
- The study proposes a multimodal therapeutic strategy based on potential pathological mechanisms.
- An algorithm for concomitant multimodal therapy for IC/BPS has been developed.
- The proposed algorithm aims to provide a rational approach to managing IC/BPS.
Conclusions:
- A structured, multimodal therapeutic approach is suggested for IC/BPS.
- The proposed algorithm offers a framework for addressing the complexity of IC/BPS.
- Further research is needed to elucidate the efficacy and durability of proposed multimodal therapies.
More Related Videos
Related Concept Videos
Drugs for Treatment of Constipation-Predominant IBS
Drugs for Treatment of Diarrhea-Predominant IBS
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
Irritable Bowel Syndrome III: Medical and Nursing Management
Inflammatory Bowel Disease IV: Pharmacological Management
Pharmacologic...
Analgesia and Pain Management
Irritable Bowel Syndrome I: Introduction
IBS is a chronic condition that can persist over a long period or recur frequently.
The pathogenesis of IBS involves a complex interplay of the following factors:
Altered...

